- Ownership hops held
- 54
An absent edge means not yet observed — never does not exist.
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. — US company (sec:0001725160). UBO chain traced 54 hops, 14 owners. Every claim linked to its source.
Ownership resolves 54 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Zentalis Pharmaceuticals, Inc.
None in current sources.
54-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on Zentalis Pharmaceuticals, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
28 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BLACKWELL KIMBERLYAlso holds roles at 2 other companies
- Century Therapeutics, Inc.director
- Monte Rosa Therapeutics, Inc.director
- BUCHER JAMES BAlso holds roles at 3 other companies
- HARPOON THERAPEUTICS, INC.officer
- Climb Bio, Inc.officer
- ALDER BIOPHARMACEUTICALS INCofficer
- EASTLAND JULIA MARIEAlso holds roles at 6 other companies
- Lantheus Holdings, Inc.director
- DYNAVAX TECHNOLOGIES CORPdirector
- HARPOON THERAPEUTICS, INC.officer
- Epperly Melissa B,Also holds roles at 3 other companies
- Roivant Sciences Ltd.director
- Nautilus Biotechnology, Inc.director
- KINNATE BIOPHARMA INC.director
- Gallagher CamAlso holds roles at 2 other companies
- Opus Genetics, Inc.director
- QUIKBYTE SOFTWARE INCdirector
- GOEL DAVID E.Also holds roles at 12 other companies
- Aura Biosciences, Inc.tenpercentowner
- ALUMIS INC.director
- ACELYRIN, Inc.other
- HALVORSEN OLE ANDREASAlso holds roles at 30 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- HAUSMAN DIANAAlso holds roles at 3 other companies
- Immuneering Corpdirector
- ZYMEWORKS BC INC.officer
- BIOMIRA CORPofficer
- MATRIX CAPITAL MANAGEMENT COMPANY, LLCAlso holds roles at 4 other companies
- Aura Biosciences, Inc.tenpercentowner
- Adaptive Biotechnologies Corpdirectorother
- Adaptive Biotechnologies Corptenpercentownerother
- MYERS SCOTT DUNSETHAlso holds roles at 11 other companies
- DYNAVAX TECHNOLOGIES CORPdirector
- HARPOON THERAPEUTICS, INC.director
- Cartesian Therapeutics, Inc.director
- Ott David C.Also holds roles at 30 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Shabet Rose SharonAlso holds roles at 26 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Skvarka JanAlso holds roles at 3 other companies
- Monte Rosa Therapeutics, Inc.director
- TRILLIUM THERAPEUTICS INC.officer
- TRILLIUM THERAPEUTICS INC.director
- SUN ANTHONY YAlso holds roles at 3 other companies
- EYENOVIA, INC.director
- ARAVIVE, INC.director
- ARAVIVE, INC.tenpercentowner
- VIKING GLOBAL INVESTORS LPAlso holds roles at 30 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities GP LLCAlso holds roles at 28 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities Illiquid Investments Sub-Master LPAlso holds roles at 27 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Viking Global Opportunities Portfolio GP LLCAlso holds roles at 28 other companies
- ACUREN CORP10% owner
- BridgeBio Pharma, Inc.10% owner
- Inhibrx Biosciences, Inc.tenpercentowner
- Walker Luke NathanielAlso holds roles at 3 other companies
- Context Therapeutics Inc.director
- HARPOON THERAPEUTICS, INC.officer
- BIOMIRA CORPofficer
28 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Zentalis Pharmaceuticals, Inc.?
- What is Zentalis Pharmaceuticals, Inc.'s risk level?
- Where does Zentalis Pharmaceuticals, Inc. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for Zentalis Pharmaceuticals, Inc. — nothing is disclosed before that.